University of Utah Health researchers have shown that a protein involved in cancer growth also plays a role in whether a ...

From increasing price transparency to curbing prescription drug costs, states are trying to figure out how to rein in rising ...

In theory, agentic AI’s ability to self-refine could mean improved patient outcomes. Hennessy says it also raises questions for regulators and end users, because assessments of AI agents will quickly ...

The FDA has approved Mimrylo (rusfertide) to treat adults with polycythemia vera (PV), a blood cancer that causes the overproduction of red blood cells. The excess cells thicken t ...

Repatha (evolocumab) lowered the risk of death from any cause by 20% in high-risk adults without a previous heart attack or ...

The FDA has approved Lilly’s Mounjaro (tirzepatide) to lower the risk of major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal heart attack, or non-fatal stroke in ...

Margaret A. Murray, M.P.A., CEO of the Association for Community Affiliated Plans, says outreach and texting will be key to keeping eligible Medicaid enrollees covered under new redetermination and ...

University of Maryland researchers used machine learning models trained on claims data of adults with diabetes to predict ...

The FDA has approved Lisraya (brepocitinib) to treat adults with dermatomyositis, rare autoimmune disease. Dermatomyositis ...

The FDA has approved ViiV Healthcare’s Tivicay PD (dolutegravir) for pediatric patients weighing at least 2 kg, according to ...

A large multicenter trial testing intravenous arginine as a treatment for acute pain crises in sickle cell patients has ended ...

The FDA has approved Rasonque (daraxonrasib), a first-in-class targeted therapy for metastatic pancreatic cancer, more than ...